Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates

Indian Journal of Medical Research

Volumn 133, Issue 5, 2011, Pages 535-540

  Singh, Mradula ^a   Jadaun, G P S ^a   Ramdas, ^a   Srivastava, K ^a   Chauhan, Vipin ^a   Mishra, Ritu ^a   Gupta, Kavita ^a   Nair, Surya ^a   Chauhan, D S ^a   Sharma, V D ^a   Venkatesan, K ^a   Katoch, V M ^a,b  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

Drug resistance; Efflux pump inhibitors; MIC; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis

Indexed keywords

2,4 DINITROPHENOL; ABC TRANSPORTER; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; OFLOXACIN; VERAPAMIL; BACTERIAL PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); PRIMER DNA;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS; ANTIBIOTIC RESISTANCE; BIOLOGY; COMPARATIVE STUDY; DNA SEQUENCE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE;

2,4-DINITROPHENOL; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BASE SEQUENCE; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; COMPUTATIONAL BIOLOGY; DNA GYRASE; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; VERAPAMIL;

EID: 79958048614     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. De Rossi E, Ainsa JA, Riccardi G. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 2006; 30: 36-52.
2. Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Gyrase mutations in laboratory- selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother; 40: 1768-1774.
3. Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth B, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994; 38: 773-80.
4. Siddiqi N, Shamim M, Hussain S, Choudhary RK, Ahmed N, Prachee S, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002; 46: 443-50.
5. Sulochana S, Narayanan S, Paramasivan CN, Suganthi C, Narayanan PR. Analysis of fluoroqunolone resistance in clinical isolates of Mycobacterium tuberculosis from India. J Chemother 2007; 19: 89-93.
6. Banerjee SK, Bhatt K, Rana S, Misra P, Chakraborti PK. Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis. Biochem Biophys Res Commun 1996; 226: 362-8.
7. Vestal AL. Procedure for the isolation and identification of mycobacteria. US Department of Health, Education and Welfare Pub no. (CDC) 77 - 8230. Atlanta, Georgia: Cente for Disease Control and Prevention; 1977. p. 65-98.
8. Martin A, Camacho M, Portaels F, Palomino JC. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: Rapid, simple and inexpensive method. Antimicrob Agents Chemother 2003; 47: 3616-9.
9. van Soolingen D, de Hass PEW, Hermans PWM, Groenen MA, van Embden JOA. Comparision of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of M. tuberculosis. J Clin Microbiol 1993; 31: 1987-95.
10. Escribano I, Rodríguez JC, Llorca B, García-Pachon E, Ruiz M, Royo G. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 2007; 53: 397-401.
11. Piddock LJ, Ricci V. Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv. J Antimicrob Chemother 2001; 48: 787-91.
12. Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis 2003; 3: 432-42.
13. Shi R, Zhang J, Li C, Kazumi Y, Sugawara I. Emergence of Ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J Clin Microbiol 2006; 44: 4566-8.
14. Sreevatsan S, Pan X, Stockbauer KE, Connell N, Kreiswirth BN, Whittam TS, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination. Proc Natl Acad Sci USA 1997; 94: 9869-74.
15. Pitaksajjakul P, Wongwit W, Punprasit W, Eampokalap B, Peacock S, Ramasoota P. Mutations in gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB pateints in Thailand. Southeast Asian J Trop Med Public Health 2005; 36: 228-37.
16. Huang TS, Kunin CM, Shin-Jung LS, Chen YS, Tu HZ, Liu YC. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother 2005; 56: 1058-62.
17. Gupta AK, Chauhan DS, Srivastava K, Das R, Batra S, Mittal M, et al. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J Commun Dis 2006; 38: 246-54.